Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

about

Severe depression as a neuropsychiatric side effect induced by dolutegravir.

P2860

Q47815951-A085230C-0583-4E9F-B013-E97CD81DFDB9

P2860

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

Item

http://www.wikidata.org/entity/Q40366201

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

@en

type

Item

label

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

@en

prefLabel

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

@en

P1476

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

@en

P2093

C M Donnelly

http://www.w3.org/2001/XMLSchema#string

C R Emerson

http://www.w3.org/2001/XMLSchema#string

E J McCarty

http://www.w3.org/2001/XMLSchema#string

E Walker

http://www.w3.org/2001/XMLSchema#string

M Hunter

http://www.w3.org/2001/XMLSchema#string

P Rafferty

http://www.w3.org/2001/XMLSchema#string

S P Quah

http://www.w3.org/2001/XMLSchema#string

Sej Todd

http://www.w3.org/2001/XMLSchema#string

W W Dinsmore

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.

P304

1074-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0956462416688127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28118801

http://www.w3.org/2001/XMLSchema#string

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

about

P2860

P2860

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698